Ursolic acid: A natural pentacyclic triterpenoid with clinical promise in gynecological and breast cancers (Review)

Gynecological and breast cancers pose significant challenges to women's health worldwide. Despite notable advancements in diagnosis and treatment, they remain leading causes of cancer-related mortality. Ursolic acid (UA), a naturally occurring pentacyclic triterpenoid widely found in plants, has garnered considerable attention due to its diverse pharmacological activities. It has been demonstrated that UA exhibits a range of biological effects, including antitumor, anti-inflammatory, and antioxidant properties, with particularly promising therapeutic potential in breast and gynecological cancers. UA exerts its anticancer effects by modulating multiple signaling pathways, such as PI3K/AKT, NF-κB, and Wnt/β-catenin, thereby effectively inhibiting tumor cell proliferation, inducing apoptosis, reversing chemoresistance, and suppressing cancer stem cell characteristics. When combined with chemotherapeutic agents such as cisplatin and doxorubicin, UA not only enhances antitumor efficacy but also mitigates the adverse effects associated with chemotherapy. The present review summarizes the recent research progress and underlying mechanisms of UA in the treatment of gynecological and breast cancers, aiming to provide valuable insights for researchers and clinicians in the field.

• Publication year

  2025

• Venue

  Oncology Report

• Publication date

  2025-09-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/or.2025.8986PMID 40937560PMCID 12452220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ursolic acid derivative UA312 ameliorates ionizing radiation-induced cardiotoxicity and neurodevelopmental toxicity in zebrafish via targeting chrna3 and grik5

  2025cited by this paper
• Promising approaches in the extraction, characterization, and biotechnological applications of ursolic acid: a review

  2025cited by this paper
• EYA3 regulation of NF-κB and CCL2 suppresses cytotoxic NK cells in the premetastatic niche to promote TNBC metastasis

  2025cited by this paper
• Advances in cancer immunotherapy: historical perspectives, current developments, and future directions

  2025cited by this paper
• Drug delivery for platinum therapeutics.

  2025cited by this paper
• Immune evasion in ovarian cancer: implications for immunotherapy and emerging treatments.

  2025cited by this paper
• A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities

  2025cited by this paper
• Potential Pharmacological Properties of Triterpene Derivatives of Ursolic Acid

  2024cited by this paper
• Cancer stem cell mimicry for immune evasion and therapeutic resistance.

  2024cited by this paper
• Ursolic acid inhibits the proliferation of triple‑negative breast cancer stem‑like cells through NRF2‑mediated ferroptosis

  2024cited by this paper
• Exploiting temporal aspects of cancer immunotherapy

  2024cited by this paper
• Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer.

  2024cited by this paper
• Supramolecular gel with enhanced immunomodulatory effects presents a minimally invasive treatment strategy for eosinophilic chronic rhinosinusitis.

  2024cited by this paper
• Ursolic Acid Inhibits Glycolysis of Ovarian Cancer via KLF5/PI3K/AKT Signaling Pathway.

  2024cited by this paper
• Cytotoxic Autophagy: A Novel Treatment Paradigm against Breast Cancer Using Oleanolic Acid and Ursolic Acid

  2024cited by this paper
• The Latest Research Progress: Active Components of Traditional Chinese Medicine as Promising Candidates for Ovarian Cancer Therapy.

  2024cited by this paper
• Improving Water Solubility and Skin Penetration of Ursolic Acid through a Nanofiber Process to Achieve Better In Vitro Anti-Breast Cancer Activity

  2024cited by this paper
• Therapeutic potential and novel formulations of Ursolic Acid and its Derivatives: An updated review.

  2023cited by this paper
• Ursolic acid derivative UAOS-Na treats experimental autoimmune encephalomyelitis by immunoregulation and protecting myelin

  2023cited by this paper
• Ursolic acid regulates key EMT transcription factors, induces cell cycle arrest and apoptosis in MDA‐MB‐231 and MCF‐7 breast cancer cells, an in‐vitro and in silico studies

  2023cited by this paper
• Clinical and translational advances in ovarian cancer therapy

  2023cited by this paper
• Gynecologic and Breast Cancers: What's New in Chemoresistance and Chemosensitivity Tests?

  2023cited by this paper
• Basic research on curcumin in cervical cancer: Progress and perspectives.

  2023cited by this paper
• Extraction of Ursolic Acid from Apple Peel with Hydrophobic Deep Eutectic Solvents: Comparison between Response Surface Methodology and Artificial Neural Networks

  2023cited by this paper
• Ursolic acid: a pentacyclic triterpenoid that exhibits anticancer therapeutic potential by modulating multiple oncogenic targets

  2023cited by this paper
• Ursolic Acid Derivative UA232 Promotes Tumor Cell Apoptosis by Inducing Endoplasmic Reticulum Stress and Lysosomal Dysfunction

  2022cited by this paper
• Inhibitory Effect of Ursolic Acid on the Migration and Invasion of Doxorubicin-Resistant Breast Cancer

  2022cited by this paper
• Inhibitory Effects of Ursolic Acid on the Stemness and Progression of Human Breast Cancer Cells by Modulating Argonaute-2

  2022cited by this paper
• Ursolic Acid Impairs Cellular Lipid Homeostasis and Lysosomal Membrane Integrity in Breast Carcinoma Cells

  2022cited by this paper
• Ursolic acid augments the chemosensitivity of drug-resistant breast cancer cells to doxorubicin by AMPK-mediated mitochondrial dysfunction.

  2022cited by this paper
• Ursolic Acid Enhances the Sensitivity of MCF-7 and MDA-MB-231 Cells to Epirubicin by Modulating the Autophagy Pathway

  2022cited by this paper
• Advances in production and structural derivatization of the promising molecule ursolic acid

  2021cited by this paper
• Synthesis and antileukemic activity of an ursolic acid derivative: a potential co-drug in combination with imatinib.

  2021cited by this paper
• Gynecological sarcomas: literature review of 2020

  2021cited by this paper
• Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer.

  2021cited by this paper
• Research Advances in Protective Effects of Ursolic Acid and Oleanolic Acid Against Gastrointestinal Diseases.

  2021cited by this paper
• Chitosan modified poly (lactic acid) nanoparticles increased the ursolic acid oral bioavailability.

  2021cited by this paper
• Ursolic Acid Enhances Cytotoxicity of Doxorubicin-Resistant Triple-Negative Breast Cancer Cells via ZEB1-AS1/miR-186-5p/ABCC1 Axis

  2021cited by this paper
• Ursolic Acid and Its Nanoparticles Are Potentiators of Oncolytic Measles Virotherapy against Breast Cancer Cells

  2021cited by this paper
• Ursolic Acid Decreases the Proliferation of MCF-7 Cell-Derived Breast Cancer Stem-Like Cells by Modulating the ERK and PI3K/AKT Signaling Pathways

  2021cited by this paper
• Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification

  2021cited by this paper
• Ursolic Acid Inhibits Breast Cancer Metastasis by Suppressing Glycolytic Metabolism via Activating SP1/Caveolin-1 Signaling

  2021cited by this paper
• Endometrial cancer

  2021cited by this paper
• Ursolic acid protects against cisplatin-induced ototoxicity by inhibiting oxidative stress and TRPV1-mediated Ca2+-signaling

  2020cited by this paper
• Accelerating the development of innovative cellular therapy products for the treatment of cancer.

  2020cited by this paper
• Gynecologic cancer in pregnancy.

  2020cited by this paper
• The Analysis of the Anti-Tumor Mechanism of Ursolic Acid Using Connectively Map Approach in Breast Cancer Cells Line MCF-7

  2020cited by this paper
• Anticancer activity of ursolic acid on human ovarian cancer cells via ROS and MMP mediated apoptosis, cell cycle arrest and downregulation of PI3K/AKT pathway.

  2020cited by this paper
• The anti-proliferative activity of ursolic acid in MDA-MB-231 human breast cancer cells through Nrf2 pathway regulation.

  2020cited by this paper
• Triple Negative Breast Cancer and Breast Epithelial Cells Differentially Reprogram Glucose and Lipid Metabolism upon Treatment with Triterpenic Acids

  2020cited by this paper
• Ursolic Acid-Based Derivatives as Potential Anti-Cancer Agents: An Update

  2020cited by this paper
• Ursolic acid reduces Adriamycin resistance of human ovarian cancer cells through promoting the HuR translocation from cytoplasm to nucleus

  2020cited by this paper
• Ursolic acid: A systematic review of its pharmacology, toxicity and rethink on its pharmacokinetics based on PK-PD model.

  2020cited by this paper
• Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p.

  2020cited by this paper
• Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin

  2019cited by this paper
• Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer

  2019cited by this paper
• Ursolic Acid and Its Derivatives as Bioactive Agents

  2019cited by this paper
• Quercetin: a natural compound for ovarian cancer treatment

  2019cited by this paper
• Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA-149-5p/MyD88

  2019cited by this paper
• Ursolic acid promotes the apoptosis of cervical cancer cells by regulating endoplasmic reticulum stress

  2019cited by this paper
• Combinational strategy for high-performance cancer chemotherapy.

  2018cited by this paper
• Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer

  2018cited by this paper
• Ursolic acid nanoparticles inhibit cervical cancer growth in vitro and in vivo via apoptosis induction.

  2017cited by this paper
• Cancer stem cells revisited

  2017cited by this paper
• Ursolic acid from apple pomace and traditional plants: A valuable triterpenoid with functional properties.

  2017cited by this paper
• Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K/AKT and NF-κB signaling pathways in vitro

  2017cited by this paper
• Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases

  2017cited by this paper
• Ursolic acid derivative FZU-03,010 inhibits STAT3 and induces cell cycle arrest and apoptosis in renal and breast cancer cells

  2017cited by this paper
• Evaluation and prevention of the negative matrix effect of terpenoids on pesticides in apples quantification by gas chromatography-tandem mass spectrometry.

  2017cited by this paper
• A novel synthetic ursolic acid derivative inhibits growth and induces apoptosis in breast cancer cell lines

  2017cited by this paper
• Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells

  2017cited by this paper
• Synthesis, structural studies, and cytotoxic evaluation of novel ursolic acid hybrids with capabilities to arrest breast cancer cells in mitosis

  2017cited by this paper
• Folate-Chitosan Nanoparticles Loaded with Ursolic Acid Confer Anti-Breast Cancer Activities in vitro and in vivo

  2016cited by this paper
• Ursolic acid (UA): A metabolite with promising therapeutic potential.

  2016cited by this paper
• Genetic risk factors of cisplatin induced ototoxicity in adult patients.

  2016cited by this paper
• Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro.

  2016cited by this paper
• A novel co-drug of aspirin and ursolic acid interrupts adhesion, invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFR-mediated signaling pathways: multiple targets for cancer metastasis prevention and treatment

  2016cited by this paper
• Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.

  2015cited by this paper
• Tumor glycolysis as a target for cancer therapy: progress and prospects

  2013cited by this paper
• Ursolic acid promotes cancer cell death by inducing Atg5‐dependent autophagy

  2013cited by this paper
• Effect of Ursolic Acid on MAPK in Cyclin D1 Signaling and RING-Type E3 Ligase (SCF E3s) in Two Endometrial Cancer Cell Lines

  2013cited by this paper
• Autophagy-dependent EIF2AK3 activation compromises ursolic acid-induced apoptosis through upregulation of MCL1 in MCF-7 human breast cancer cells

  2013cited by this paper
• Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies.

  2013cited by this paper
• Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells.

  2012cited by this paper
• Ultrasound-assisted extraction of oleanolic acid and ursolic acid from Ligustrum lucidum Ait.

  2012cited by this paper
• Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells

  2012cited by this paper
• Microwave-Assisted Extraction of Oleanolic Acid and Ursolic Acid from Ligustrum lucidum Ait

  2011cited by this paper
• Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.

  2010cited by this paper
• Antitumor Effects of Ursolic Acid in a Mouse Model of Postmenopausal Breast Cancer

  2010cited by this paper
• Enhancement of chemotherapeutic agent‐induced apoptosis by inhibition of NF‐κB using ursolic acid

  2010cited by this paper
• Ursolic Acid Triggers Apoptosis and Bcl-2 Downregulation in MCF-7 Breast Cancer Cells

  2009cited by this paper
• Regulation of the Phosphatidylinositol 3-Kinase-Akt and the Mitogen-Activated Protein Kinase Pathways by Ursolic Acid in Human Endometrial Cancer Cells

  2007cited by this paper
• Antiproliferative and antiviral mechanisms of ursolic acid and dexamethasone in cervical carcinoma cell lines

  2006cited by this paper
• Proteomic analysis of ursolic acid-induced apoptosis in cervical carcinoma cells.

  2006cited by this paper
• Molecular mechanism of ursolic acid induced apoptosis in poorly differentiated endometrial cancer HEC108 cells.

  2005cited by this paper
• Ursolic acid induces Bax-dependent apoptosis through the caspase-3 pathway in endometrial cancer SNG-II cells.

  2005cited by this paper
• Human Papillomavirus and Cervical Cancer

  2003cited by this paper

• No citing papers are available for this paper.